CD133 expression was strong in two of three Nes+ cell lines (OSA-02, and OSA-03) as well as in the control Saos-2 cell line, whereas medium immunoreactivity was detected in Nes+ OSA-01 cell line and in nestin-negative OSA-5 cell line. This evidence concerns the gene PROM1 and obstructive sleep apnea syndrome.